West Pharmaceutical Services (WST) said Thursday that Chief Financial Officer Bernard Birkett plans to retire later this year and that a search for his successor is underway.
Birkett is expected to remain in the CFO role until a successor is appointed and will then serve as an advisor to support a smooth transition, the company said.
West also said it appointed Shane Campbell as chief proprietary segment officer, starting May 5. Campbell most recently served as chief commercial officer of the construction materials business at Carlisle (CSL).
Shares of West Pharmaceutical Services were down 3.5% in recent trading.
Price: 210.50, Change: -7.68, Percent Change: -3.52
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.